Abstract P154 – Table 1. Factors associated with the risk of progression (from no MAFLD to MAFLD) or regression (from MAFLD to no MAFLD).
Path	No MAFLD to MAFLD (progression)	MAFLD to no MAFLD (regression)
Age (continuous)	1.02 (1 to 1.04)	0.99 (0.97 to 1.02)
Male sex (vs female)	0.55 (0.32 to 0.95)	0.51 (0.31 to 0.85)
Years since HIV diagnosis (10 to 20 vs <10 years)	0.95 (0.53 to 1.70)	0.85 (0.47 to 1.56)
Years since HIV diagnosis (>20 years vs <10 years)	1.00 (0.56 to 1.80)	0.98 (0.54 to 1.79)
Nadir CD4 cell count <200 c/microL (vs >200)	0.84 (0.56 to 1.26)	0.97 (0.65 to 1.45)
Weight (continuous)	1.07 (1.05 to 1.10)	0.99 (0.97 to 1.02)
INSTI ‐ non TAF (vs non INSTI non TAF)	1.33 (0.82 to 2.14)	0.91 (0.56 to 1.46)
non INSTI ‐ TAF (vs non INSTI non TAF)	0.75 (0.38 to 1.48)	0.64 (0.34 to 1.22)
INSTI ‐ TAF (vs non INSTI non TAF)	2.11 (1.11 to 3.99)	0.90 (0.45 to 1.79)